The COGNISION® System is the first easy-to-use, FDA-cleared, cloud-powered EEG/ERP system for neurocognitive biomarkers and assessment. Combining science, innovation, and data, the COGNISION® system empowers clinicians to effectively evaluate patients with dementia, concussion/mTBI, and other neurocognitive disorders. The COGNISION® system has been implemented in multiple clinical trials, advancing the use of precision EEG/ERP biomarkers in CNS drug development. We are a founding member of the EEG/ERP Biomarker Qualification Consortium: www.erpbiomarkers.org